{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:29Z","timestamp":1786988069002,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003597"],"award-info":[{"award-number":["82003597"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073710"],"award-info":[{"award-number":["82073710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["CPU2022PZQ01"],"award-info":[{"award-number":["CPU2022PZQ01"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejmech.2024.116155","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T18:34:55Z","timestamp":1705689295000},"page":"116155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: Design, synthesis and biological activities"],"prefix":"10.1016","volume":"266","author":[{"given":"Youzhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116155_bib1","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/JPR.S168188","article-title":"Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice","volume":"11","author":"Ho","year":"2018","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116155_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009740310004766","article-title":"Selective cyclooxygenase-2 inhibitors: similarities and differences","volume":"33","author":"Brune","year":"2004","journal-title":"Scand. J. Rheumatol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116155_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01062463","article-title":"Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye","volume":"20","author":"Rao","year":"1992","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejmech.2024.116155_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JAA.S164806","article-title":"NSAID-induced reactions: classification, prevalence, impact, and management strategies","volume":"12","author":"Blanca-Lopez","year":"2019","journal-title":"J. Asthma Allergy"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116155_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40261-016-0440-9","article-title":"Loxoprofen: a review in pain and inflammation","volume":"36","author":"Greig","year":"2016","journal-title":"Clin. Drug Invest."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116155_bib6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/pds.1820","article-title":"Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease","volume":"18","author":"Roumie","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116155_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.tcm.2016.04.011","article-title":"FDA labeling of NSAIDs: review of nonsteroidal anti-inflammatory drugs in cardiovascular disease","volume":"26","author":"Pirlamarla","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116155_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2024.116155_bib9","first-page":"25","article-title":"Risk of stroke associated with nonsteroidal anti-inflammatory drugs","volume":"10","author":"Park","year":"2014","journal-title":"Vasc. Health Risk Manag."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116155_bib10","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/STROKEAHA.107.508549","article-title":"Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke","volume":"39","author":"Roumie","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2024.116155_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117631","article-title":"Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: a review","volume":"251","author":"Arora","year":"2020","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116155_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/med.21424","article-title":"Nonsteroidal anti-inflammatory therapy: a journey toward safety","volume":"37","author":"Pereira-Leite","year":"2017","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116155_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/ars.2011.4335","article-title":"Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension","volume":"18","author":"Mart\u00ednez-Revelles","year":"2013","journal-title":"Antioxidants Redox Signal."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116155_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1152\/physrev.00040.2012","article-title":"Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases","volume":"94","author":"Bhattacharyya","year":"2014","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116155_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.freeradbiomed.2010.04.013","article-title":"Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis","volume":"49","author":"Pal","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116155_bib16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1124\/jpet.108.139030","article-title":"Cyclooxygenase 2-selective and nonselective nonsteroidal anti-inflammatory drugs induce oxidative stress by up-regulating vascular NADPH oxidases","volume":"326","author":"Li","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2024.116155_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/536962","article-title":"NSAIDs and cardiovascular diseases: role of reactive oxygen species","volume":"2015","author":"Ghosh","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116155_bib18","first-page":"899","article-title":"Beyond neurological disease: new targets for edaravone","volume":"28","author":"Kikuchi","year":"2011","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116155_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/etm.2011.352","article-title":"Beyond free radical scavenging: beneficial effects of edaravone (Radicut) in various diseases","volume":"3","author":"Kikuchi","year":"2012","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116155_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/antiox7010014","article-title":"Subcellular reactive oxygen species (ROS) in cardiovascular pathophysiology","volume":"7","author":"Aldosari","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2024.116155_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/318714","article-title":"ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology","volume":"2014","author":"Caliceti","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2024.116155_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mam.2018.03.002","article-title":"ROS signaling and ER stress in cardiovascular disease","volume":"63","author":"Ochoa","year":"2018","journal-title":"Mol. Aspect. Med."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116155_bib23","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.3390\/ijms140713909","article-title":"The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease","volume":"14","author":"Kikuchi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116155_bib24","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3389\/fimmu.2018.02363","article-title":"Potential role of cytochrome c and tryptase in psoriasis and psoriatic arthritis pathogenesis: focus on resistance to apoptosis and oxidative stress","volume":"9","author":"Chimenti","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.116155_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/DDDT.S391606","article-title":"Anti-arthritic effect of edaravone against complete freund adjuvant induced arthritis via osteoclast differentiation and HIF-1\u03b1-VEGF-ANG-1 Axis","volume":"17","author":"Liu","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116155_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molimm.2007.05.020","article-title":"Edaravone inhibits collagen-induced arthritis possibly through suppression of nuclear factor-kappa B","volume":"45","author":"Arii","year":"2008","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116155_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2710.2006.00722.x","article-title":"Edaravone inhibits the disease activity in rheumatoid arthritis","volume":"31","author":"Arii","year":"2006","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116155_bib28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jcb.29382","article-title":"The therapeutic effects of edaravone on collagen-induced arthritis in rats","volume":"121","author":"Zhang","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116155_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3164\/jcbn.17-62","article-title":"How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?","volume":"62","author":"Watanabe","year":"2018","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116155_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/antiox8080258","article-title":"Synthesis, characterization and antioxidant properties of a new lipophilic derivative of edaravone","volume":"8","author":"Minnelli","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2024.116155_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105159","article-title":"Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy","volume":"115","author":"Zhou","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116155_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113383","article-title":"Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction","volume":"218","author":"Guo","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116155_bib33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1021\/ml500156v","article-title":"Propyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors","volume":"5","author":"Radwan","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116155_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115374","article-title":"Design and synthesis of a novel class of PDE4 inhibitors with antioxidant properties as bifunctional agents for the potential treatment of COPD","volume":"256","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116155_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/595603","article-title":"Ameliorative effects of scopoletin from crossostephium chinensis against inflammation pain and its mechanisms in mice","author":"Chang","year":"2012","journal-title":"Evid. Based. Complement. Alternat. Med"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T22:16:57Z","timestamp":1722896217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":35,"alternative-id":["S0223523424000357"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116155","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrids of selective COX-2 inhibitors and active derivatives of edaravone as COX-2 selective NSAIDs with free radical scavenging activity: Design, synthesis and biological activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116155"}}